HEATHER HAWKINS: Open Payments
NPI 1821795394 · ROGERS, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,578 in 114 payments from 14 companies in 2025. Trend: 2023 $1,138 · 2024 $2,147 · 2025 $2,578
Food & beverage: $2,578
| Company | Payments | Amount |
|---|---|---|
| Alkermes, Inc. | 20 | $504 |
| ABBVIE INC. | 18 | $281 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 15 | $276 |
| Vanda Pharmaceuticals Inc. | 9 | $261 |
| Neurocrine BioSciences, Inc. | 11 | $258 |
| Axsome Therapeutics, Inc. | 7 | $236 |
| Teva Pharmaceuticals USA, Inc. | 8 | $171 |
| Janssen Pharmaceuticals, Inc | 5 | $111 |
| E.R. Squibb & Sons, L.L.C. | 5 | $108 |
| Lundbeck LLC | 5 | $101 |
Products named: ARISTADA, VRAYLAR, CAPLYTA, INGREZZA, Auvelity, REXULTI, HETLIOZ, AUSTEDO XR.
Industry payments across AR — which companies pay providers there.
